期刊文献+

DcR3 mRNA在白血病细胞中的表达及意义 被引量:3

Expression of DcR3 mRNA in leukemia cells and its significance
下载PDF
导出
摘要 目的:探讨DcR3 mRNA在急性白血病(AL)细胞中的表达及其临床意义。方法:选择AL患者46例,其中急性髓系白血病(AML)28例,急性淋巴细胞白血病(ALL)18例,27例非恶性血液病患者作为对照组,采用RT-PCR方法检测骨髓单个核细胞(BMNC)中DcR3 mRNA的表达水平,并分析其与临床参数的关联性。结果:AL组DcR3 mRNA表达阳性率(67.4%)及表达水平(0.56±0.09)高于对照组(40.7%,0.39±0.19)(P<0.05);AML组DcR3 mRNA表达阳性率(71.4%)及表达水平(0.56±0.09)与ALL组(61.1%,0.53±0.08)比较差异无显著性(P>0.05);AL患者DcR3 mRNA的阳性表达率在白细胞计数≥30×109.L-1时升高。结论:DcR3基因可能通过抑制白血病细胞凋亡途径参与白血病发病过程。 Objective To investigate the expression of DcR3 mRNA in cells of acute leukemia (AL) and its clinical significance. Methods The DcR3 mRNA of bone marrow mononuclear cells (BMNC) in the patients with AL was detected by RT-PCR. There were 28 AML cases, and 18 ALL cases. 27 cases of non-malignant hematopathy were used as control group. The expression level of DcR3 mRNA in BMNC was detected with RT-PCR. Results The positive rate of DcR3 mRNA was 67.4% and gene expression level was 0.56±0. 09 in AL group, while they were 40. 7% and 0. 39±0.19 in control group, there were significant differences (P〈0.05). The positive rate of DcR3 mRNA was 71.4% and the gene expression level was 0.56 ± 0.09 in AML group, while they were 61.1% and 0.53±0.08 in ALL group, there was no significant difference (P〉0.05). The positive expression level of DeR3 mRNA increased when the white blood cell count was ≥30× 10^9· L^-1.Conclusion DcR3 gene might play a role by suppressing apoptosis in leukemogenesis.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2007年第6期1050-1053,共4页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(30370617)
关键词 急性白血病 DcR3基因 基因表达 acute leukemia DcR3 gene gene expression
  • 相关文献

参考文献9

  • 1Pitti RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer [J]. Nature, 1998, 396:699-703.
  • 2Yu KY, Kwon B, Ni J, et al. A newly identified member of tumor necroslsfactor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis [ J ]. J Biol Chem, 1999, 274 (20) 113733-13736.
  • 3Bai C, Connlly B, Metzker ML, et al. Overexpression of M68/DeR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a fourgene cluster [J]. Proe Natl Aead Sei USA, 2000, 97 (3): 1230-1235.
  • 4高素君,李薇,杨芳,王冠军.恶性血液病Flt_3基因内部串联重复突变分析[J].吉林大学学报(医学版),2004,30(4):591-592. 被引量:1
  • 5王春红,卢爱平,肖忠平,姜玉珍.p16基因甲基化与急性淋巴细胞白血病的关系[J].吉林大学学报(医学版),2005,31(1):124-126. 被引量:1
  • 6Friesen C, Kiess Y. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells [J]. Cell Death Differ, 2004, 11 (Suppl 1):S73-85.
  • 7Lee JJ, Chung IJ, Park MR, et al. Increased anglo genesis and Fas-ligand expression are independent processes in acute myeloid leukemia [ J]. Leukemia Res, 2001, 25 (12):1067-1073.
  • 8Wu Y, Han B, Sheng H, et al. Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients [J]. Int J Cancer, 2003, 105 (5): 724-732.
  • 9Takahama Y, Yamada Y, Emoto K, et al. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas [J]. Gastric Cancer, 2002, 5 (2):61-68.

二级参考文献16

  • 1Guo SX, Taki T, Ohnishi H, et al. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia[J].Leu Res, 2000, 24 (1): 39-46.
  • 2Baur AS, Shaw P, Burri N, et al. Frequent methylation silencing of p15INK4b (MTS2) and p16INKa (MTS1) in B-cell and T-cell lymphomas [J]. Blood, 1999, 94 (5): 1773-1781.
  • 3Reed AL, Califano J, Cairas P, et al. High frequency of p16 (CDKN2/MTS1/INK4A) inactivation in head and neck squamous cell carcinoma[J]. Cancer Res, 1996,56: 3630-3633.
  • 4Nosaka K, Maeda M, Tamiya S, et al. Increasing mehylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia [J]. Cancer Res, 2000, 60: 1003-1010.
  • 5Gonzalez-Zulueta M, Bender CM ,Yang AS, et al. Methylation of the 5, CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with silencing [J]. Cancer Res, 1995, 55: 4531-4535.
  • 6Lee JH, Park SJ, Abraham SC, et al. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas [J]. Oncogene, 2004, 23 (26): 4646-4654.
  • 7Suzuki M, Sunaga N, Shames DS, et al. RNA interferencemediated knockdown of DNA methyltransferase leads to promoter demethylation and gene re-expression in human lung and breast cancer cells [J]. Cancer Res, 2004, 64 (9): 3137-3143.
  • 8Mathews W, Jordan CT, Wiegand GW, et al. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations [J]. Cell, 1991, 65: 1143-1152.
  • 9Carow CE, levenstein M, Kaufmann SH, et al. Expression of the hematopoietic growth factor receptor Flt3 (STK-1/FlK2) in human leukemia [J]. Blood, 1996, 87: 1089-1096.
  • 10Horiike S, Yokotas, Nakao M, et al. Tandem duplications of the Flt3 receptor gene are associated with leukemia transformation of myelodysplasia [J]. Leukemia, 1997, 11:1442-1446.

同被引文献27

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部